7th Annual State-of-the-Art in Thrombosis and Hemostasis Symposium

7th Annual State-of-the-Art in Thrombosis and Hemostasis Symposium is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held on Sep 16, 2018 at Mortimer B. Zuckerman Research Center, New York City, New York, United States of America.

The target audience for this medical event is Hematologists. This CME Conference has been approved for a maximum of 6.5 AMA PRA Category 1 Credits.

Course Description:
This course is designed to provide an important annual educational forum for Hematology and Oncology doctors. The ultimate objective of this activity is to enhance physician understanding of the disease state and treatment advances for the benefit of patients. This course is intended for hematology/oncology practitioners, fellows, advanced practice providers and other healthcare professionals in the field.

Course Objectives:
•Understand the current standard of care for use of the direct oral anticoagulants (DOACs). What is their safety and efficacy profiles
•Understand the evolving role of coagulation testing in diagnosing and managing coagulation disorders. This includes the effect of the DOACs on routine coagulation tests, and what is the role of testing for levels of the new generation of anticoagulants.
•How can Interventional Radiology be best utilized for management of thrombosis? When is IVC filter appropriate What are the growing role of thrombolysis and venous stent placement.
•How is hemolytic anemia associated with an increased risk of thrombosis
•The association of thrombosis with cancer has been recognized for over 150 years. What is the current understanding of pathophysiology and management
•Understand mechanisms by which mutations within cancer cells activates the coagulation system.